Additional prognostic value of the BCT score in ER+HER2- breast cancer patients receiving a 21-gene assay-guided adjuvant treatments.
Saved in:
| Title: | Additional prognostic value of the BCT score in ER+HER2- breast cancer patients receiving a 21-gene assay-guided adjuvant treatments. |
|---|---|
| Authors: | Ahn SG; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Yu J; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Baek SH; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim YJ; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Kim WY; Department of Breast and Endocrine Surgery, Korea University Guro Hospital, Seoul, Republic of Korea., Chung JH; Department of Breast and Endocrine Surgery, Korea University Guro Hospital, Seoul, Republic of Korea., Bae SJ; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim SW; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Nam SJ; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Gong G; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Lee YW; Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea., Han JH; Department of Surgery, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Jeong J; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Woo SU; Department of Breast and Endocrine Surgery, Korea University Guro Hospital, Seoul, Republic of Korea., Lee EG; Department of Surgery, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea., Lee SB; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Apr 16; Vol. 15, pp. 1517073. Date of Electronic Publication: 2025 Apr 16 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40308501 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Additional prognostic value of the BCT score in ER+HER2- breast cancer patients receiving a 21-gene assay-guided adjuvant treatments. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ahn+SG%22">Ahn SG</searchLink>; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yu+J%22">Yu J</searchLink>; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Baek+SH%22">Baek SH</searchLink>; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+YJ%22">Kim YJ</searchLink>; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+WY%22">Kim WY</searchLink>; Department of Breast and Endocrine Surgery, Korea University Guro Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Chung+JH%22">Chung JH</searchLink>; Department of Breast and Endocrine Surgery, Korea University Guro Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Bae+SJ%22">Bae SJ</searchLink>; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SW%22">Kim SW</searchLink>; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Nam+SJ%22">Nam SJ</searchLink>; Breast Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Gong+G%22">Gong G</searchLink>; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+YW%22">Lee YW</searchLink>; Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Han+JH%22">Han JH</searchLink>; Department of Surgery, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jeong+J%22">Jeong J</searchLink>; Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Woo+SU%22">Woo SU</searchLink>; Department of Breast and Endocrine Surgery, Korea University Guro Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+EG%22">Lee EG</searchLink>; Department of Surgery, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SB%22">Lee SB</searchLink>; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Apr 16; Vol. 15, pp. 1517073. <i>Date of Electronic Publication: </i>2025 Apr 16 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40308501 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1517073 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1517073 Titles: – TitleFull: Additional prognostic value of the BCT score in ER+HER2- breast cancer patients receiving a 21-gene assay-guided adjuvant treatments. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ahn SG – PersonEntity: Name: NameFull: Yu J – PersonEntity: Name: NameFull: Baek SH – PersonEntity: Name: NameFull: Kim YJ – PersonEntity: Name: NameFull: Kim WY – PersonEntity: Name: NameFull: Chung JH – PersonEntity: Name: NameFull: Bae SJ – PersonEntity: Name: NameFull: Kim SW – PersonEntity: Name: NameFull: Nam SJ – PersonEntity: Name: NameFull: Gong G – PersonEntity: Name: NameFull: Lee YW – PersonEntity: Name: NameFull: Han JH – PersonEntity: Name: NameFull: Jeong J – PersonEntity: Name: NameFull: Woo SU – PersonEntity: Name: NameFull: Lee EG – PersonEntity: Name: NameFull: Lee SB IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 04 Text: 2025 Apr 16 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |